Wells Fargo initiated coverage of Moelis with a rating of Equal Weight and set a new price target of $70.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/13/2025 | $100.00 → $70.00 | Overweight → Underweight | Morgan Stanley |
| 12/20/2024 | $71.00 → $86.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 12/9/2024 | $66.00 → $92.00 | Underweight → Overweight | Morgan Stanley |
| 9/12/2024 | $70.00 | Equal Weight | Wells Fargo |
| 3/13/2024 | $53.00 → $58.00 | Sell → Neutral | Goldman |
| 1/29/2024 | $56.00 | Mkt Perform | Keefe Bruyette |
| 1/11/2023 | $40.00 → $37.00 | Neutral → Sell | Goldman |
| 11/3/2022 | $40.00 → $37.00 | Mkt Perform → Underperform | Keefe Bruyette |
Morgan Stanley downgraded Moelis from Overweight to Underweight and set a new price target of $70.00 from $100.00 previously
Keefe Bruyette upgraded Moelis from Mkt Perform to Outperform and set a new price target of $86.00 from $71.00 previously
Morgan Stanley upgraded Moelis from Underweight to Overweight and set a new price target of $92.00 from $66.00 previously
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)